| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Gt Biopharma, Inc. (GTBP) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 1 sell. GTBP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 100.0K | $37.5K | - | |
| Dir | 62.5K | $23.4K | - | |
| CFO | 50.0K | $18.8K | - | |
| Dir | 31.3K | $11.7K | - | |
| Dir | 31.3K | $11.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 4, 2016 | Bristol Investment Fund Ltd | 10% Owner | Sell | 675,000 | $0.00 | - | -30.7% |